Specificity of T Cells Invading the Skin During Acute Graft-vs.-host Disease After Semiallogeneic Bone Marrow Transplantation

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1993 Jan 1

PMID 8423212

Citations 3

Authors

J Gaschet

B Mahe

N Milpied

M C Devilder

B Dreno

J D Bignon

F Davodeau

M M Hallet

M Bonneville

H Vie

Affiliations

Soon will be listed here.

Abstract

The mechanisms responsible for skin lesions during acute graft-vs.-host disease (aGVHD) after allogeneic bone marrow transplantation (BMT) are poorly understood. The exact role of various effector cell populations and "major" (particularly HLA-DP) or "minor" antigens as target molecules is not known. To investigate the nature of cells responsible for tissue injury, we cultured T cells from skin biopsy first with interleukin 2 (IL-2) alone and then in polyclonal activation conditions to avoid in vitro antigenic sensitization before specificity testing. We applied this method to two biopsies performed during aGVHD after semiallogeneic BMT and obtained cytotoxic T cells against four graft mismatches: CD8+ T cells against HLA-A2.2 and HLA-B27 and CD4+ T cells against HLA-DP101 and HLA-DP401. This demonstrates that T cells with documented specificity can be obtained from an aGVHD lesion without antigenic selection. Moreover, these data directly implicate DP as a potential target antigen for aGVHD.

Citing Articles

GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.

Hess N, Brown M, Capitini C Front Immunol. 2021; 12:723544.

PMID: 34394131 PMC: 8358790. DOI: 10.3389/fimmu.2021.723544.

Lymphocytes, cytokines and adhesion molecules in chronic graft versus host disease.

Aractingi S, Gluckman E, Le Goue C, Dubertret L, Carosella E Clin Mol Pathol. 1996; 49(4):M225-31.

PMID: 16696080 PMC: 408064. DOI: 10.1136/mp.49.4.m225.

Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

Gaschet J, Lim A, Liem L, Vivien R, Hallet M, Harousseau J J Clin Invest. 1996; 98(1):100-7.

PMID: 8690780 PMC: 507405. DOI: 10.1172/JCI118753.

References

Goulmy E, Gratama J, Blokland E, Zwaan F, van Rood J . A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature. 1983; 302(5904):159-61. DOI: 10.1038/302159a0. View

Niederwieser D, Aubock J, Troppmair J, Herold M, Schuler G, Boeck G . IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J Immunol. 1988; 140(8):2556-64. View

Kaye V, Neumann P, Kersey J, GOLTZ R, Baldridge B, Michael A . Identity of immune cells in graft-versus-host disease of the skin. Analysis using monoclonal antibodies by indirect immunofluorescence. Am J Pathol. 1984; 116(3):436-40. PMC: 1900457. View

Sims J, Tunnacliffe A, Smith W, Rabbitts T . Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes. Nature. 1984; 312(5994):541-5. DOI: 10.1038/312541a0. View

Reinsmoen N, Kersey J, Bach F . Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions. Hum Immunol. 1984; 11(4):249-57. DOI: 10.1016/0198-8859(84)90064-8. View

Minami M, Kawasaki H, Taira S, Nariuchi H . Alloantigen presentation by B cells: two types of alloreactive T cell hybridomas, B cell-reactive and B cell-nonreactive. J Immunol. 1985; 135(1):111-6. View

Martin P, Hansen J, Buckner C, Sanders J, Deeg H, Stewart P . Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood. 1985; 66(3):664-72. View

Guyotat D, Mauduit G, Chouvet B, Kanitakis J, Van H, Fiere D . A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation. Transplantation. 1986; 41(3):340-2. DOI: 10.1097/00007890-198603000-00011. View

Lefranc M, Forster A, Baer R, Stinson M, Rabbitts T . Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups. Cell. 1986; 45(2):237-46. DOI: 10.1016/0092-8674(86)90388-0. View

10.

Nickoloff B, Basham T, Merigan T, Torseth J, Morhenn V . Human keratinocyte-lymphocyte reactions in vitro. J Invest Dermatol. 1986; 87(1):11-8. DOI: 10.1111/1523-1747.ep12523513. View

11.

Kernan N, Collins N, Juliano L, Cartagena T, DuPont B, OReilly R . Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 1986; 68(3):770-3. View

12.

Breathnach S, Shimada S, Kovac Z, Katz S . Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes. J Invest Dermatol. 1986; 86(3):226-34. DOI: 10.1111/1523-1747.ep12285176. View

13.

Pawelec G, Ehninger G, Schmidt H, Wernet P . HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation. Transplantation. 1986; 42(5):558-60. View

14.

Herve P, Cahn J, Flesch M, Plouvier E, Racadot E, NOIR A . Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement. Blood. 1987; 69(2):388-93. View

15.

Maraninchi D, Gluckman E, Blaise D, Guyotat D, Rio B, Pico J . Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet. 1987; 2(8552):175-8. DOI: 10.1016/s0140-6736(87)90763-x. View

16.

Picker L, Michie S, Rott L, Butcher E . A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol. 1990; 136(5):1053-68. PMC: 1877421. View

17.

van Els C, Bakker A, Zwinderman A, Zwaan F, van Rood J, Goulmy E . Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I. Absence of correlation with cytotoxic effector cells. Transplantation. 1990; 50(1):62-6. DOI: 10.1097/00007890-199007000-00011. View

18.

Odum N, Platz P, Jakobsen B, Petersen C, Jacobsen N, Moller J . HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute graft versus host disease. Tissue Antigens. 1987; 30(5):213-6. DOI: 10.1111/j.1399-0039.1987.tb01624.x. View

19.

Kirk A, Ibrahim M, Bollinger R, Dawson D, Finn O . Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. Transplantation. 1992; 53(2):329-38. DOI: 10.1097/00007890-199202010-00014. View

20.

Marrack P, Kappler J . T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature. 1988; 332(6167):840-3. DOI: 10.1038/332840a0. View